Which statement best describes the use of misoprostol (Cytotec) in postpartum hemorrhage management?

Which statement best describes the use of misoprostol (Cytotec) in postpartum hemorrhage management?

• A. It is a prostaglandin analogue used as a uterotonic
• B. It is a thrombolytic agent used to dissolve clots
• C. It is a calcium channel blocker used to reduce uterine contractions
• D. It is an antifibrinolytic agent used to stabilize clots

Answer: (A)

Promoting uterine contraction with a prostaglandin analogue is how misoprostol helps control postpartum hemorrhage. Misoprostol acts as a uterotonic, stimulating the uterus to contract and compress bleeding vessels to reduce blood loss—especially useful when oxytocin isn’t available or as an adjunct to ongoing therapy. Its practicality in various settings stems from stability at room temperature and multiple administration routes. It is not a thrombolytic (which would dissolve clots), not a calcium channel blocker (which would lessen contractions), and not an antifibrinolytic (which would stabilize clots). In practice, oxytocin is usually first-line, with misoprostol added if needed.

Promoting uterine contraction with a prostaglandin analogue is how misoprostol helps control postpartum hemorrhage. Misoprostol acts as a uterotonic, stimulating the uterus to contract and compress bleeding vessels to reduce blood loss—especially useful when oxytocin isn’t available or as an adjunct to ongoing therapy. Its practicality in various settings stems from stability at room temperature and multiple administration routes. It is not a thrombolytic (which would dissolve clots), not a calcium channel blocker (which would lessen contractions), and not an antifibrinolytic (which would stabilize clots). In practice, oxytocin is usually first-line, with misoprostol added if needed.